Print this page    •   Back to Web version of article

Table of Contents, October 2004

The Panel Speaks

In a letter dated 10/04/04, the PHS guidelines panel notified Dr. Paul Bellman of its decision regarding the "ban" on hydroxyurea:

"Since hydroxyurea is not approved for [the treatment of HIV], we have decided to remove it from the new guidelines revision ... anticipated to be available ... at the end of October."

-- Alice K. Pau, Pharm.D., Executive Secretary, Panel on Clinical Practices for the Treatment of HIV Infection, Public Health System, Department of Health and Human Services

This article was provided by Treatment Action Group. It is a part of the publication TAGline. You can find this article online by typing this address into your Web browser:

General Disclaimer: is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.